Accordant Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516K Hold
2,031
0.35% 38
2026
Q1
$496K Buy
2,031
+100
+5% +$23.3K 0.31% 32
2025
Q4
$400K Hold
1,931
0.28% 39
2025
Q3
$358K Sell
1,931
-3
-0.2% -$514 0.24% 42
2025
Q2
$295K Buy
1,934
+3
+0.2% +$461 0.22% 46
2025
Q1
$320K Sell
1,931
-8,882
-82% -$1.39M 0.31% 28
2024
Q4
$1.56M Sell
10,813
-83
-0.8% -$12.9K 1.51% 20
2024
Q3
$1.77M Sell
10,896
-9,782
-47% -$1.56M 1.41% 23
2024
Q2
$3.02M Buy
20,678
+15,050
+267% +$2.24M 2.86% 10
2024
Q1
$890K Buy
+5,628
New +$896K 0.67% 39

Other funds holding JNJ

Accordant Advisory Group's JNJ Position: Q2 2026 in Review

Accordant Advisory Group held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 2,031 shares worth $516K. The position accounts for 0.35% of the portfolio, ranked #38.

Accordant Advisory Group first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.02M in Q2 2024. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Accordant Advisory Group held 2,031 shares of Johnson & Johnson worth $516K as of Q2 2026.
  • Accordant Advisory Group left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.35% of Accordant Advisory Group's portfolio in Q2 2026, its #38 holding.
  • Accordant Advisory Group first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • Accordant Advisory Group's Johnson & Johnson position peaked at $3.02M in Q2 2024.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Accordant Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.